CollPlant Biotechnologies Ltd.
CLGN
$2.29
-$0.1295-5.35%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Net Income | -3.88M | -4.21M | -4.20M | -4.69M | |
| Total Depreciation and Amortization | 242.00K | 261.00K | 280.00K | 284.00K | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | 354.00K | 612.00K | 415.00K | 365.00K | |
| Change in Net Operating Assets | -182.00K | -591.00K | 247.00K | 1.70M | |
| Cash from Operations | -3.46M | -3.93M | -3.25M | -2.35M | |
| Capital Expenditure | -59.00K | -202.00K | -82.00K | -229.00K | |
| Sale of Property, Plant, and Equipment | 1.00K | -- | -- | 68.00K | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | 0.00 | -57.00K | -- | -211.00K | |
| Cash from Investing | -58.00K | -259.00K | -82.00K | -372.00K | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -- | -- | -- | -- | |
| Issuance of Common Stock | 0.00 | 0.00 | 9.00K | 0.00 | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | |
| Cash from Financing | 0.00 | 0.00 | 9.00K | 0.00 | |
| Foreign Exchange rate Adjustments | 60.00K | -118.00K | -123.00K | 199.00K | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -3.46M | -4.31M | -3.45M | -2.52M | |